Cencora ROE 2010-2025 | COR
Current and historical return on equity (ROE) values for Cencora (COR) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Cencora ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $1.69B | $1.18B | 199.76% |
| 2024-12-31 | $1.40B | $0.36B | 162.47% |
| 2024-09-30 | $1.51B | $0.79B | 145.94% |
| 2024-06-30 | $1.86B | $1.06B | 185.01% |
| 2024-03-31 | $1.85B | $1.23B | 191.33% |
| 2023-12-31 | $1.87B | $1.06B | 236.46% |
| 2023-09-30 | $1.75B | $0.67B | 321.40% |
| 2023-06-30 | $1.69B | $0.92B | 428.39% |
| 2023-03-31 | $1.62B | $0.51B | 550.94% |
| 2022-12-31 | $1.73B | $0.07B | 441.05% |
| 2022-09-30 | $1.70B | $0.07B | 324.24% |
| 2022-06-30 | $1.84B | $0.52B | 282.41% |
| 2022-03-31 | $1.73B | $0.91B | 276.43% |
| 2021-12-31 | $1.61B | $0.60B | 433.29% |
| 2021-09-30 | $1.54B | $0.58B | 1633.95% |
| 2021-06-30 | $-3.74B | $0.41B | 1430.37% |
| 2021-03-31 | $-3.75B | $-0.10B | -596.42% |
| 2020-12-31 | $-3.22B | $-0.51B | -203.89% |
| 2020-09-30 | $-3.41B | $-0.84B | -137.71% |
| 2020-06-30 | $1.57B | $3.97B | 45.72% |
| 2020-03-31 | $1.58B | $3.71B | 49.18% |
| 2019-12-31 | $0.65B | $3.07B | 21.30% |
| 2019-09-30 | $0.86B | $2.99B | 27.83% |
| 2019-06-30 | $0.96B | $3.11B | 30.94% |
| 2019-03-31 | $0.93B | $3.04B | 29.69% |
| 2018-12-31 | $1.19B | $3.17B | 37.03% |
| 2018-09-30 | $1.66B | $3.05B | 52.78% |
| 2018-06-30 | $1.08B | $3.28B | 37.31% |
| 2018-03-31 | $0.85B | $3.36B | 31.46% |
| 2017-12-31 | $0.98B | $2.88B | 39.03% |
| 2017-09-30 | $0.36B | $2.06B | 15.67% |
| 2017-06-30 | $0.85B | $2.55B | 36.62% |
| 2017-03-31 | $1.15B | $2.53B | 53.29% |
| 2016-12-31 | $1.35B | $2.12B | 64.69% |
| 2016-09-30 | $1.43B | $2.13B | 76.17% |
| 2016-06-30 | $1.64B | $1.88B | 109.79% |
| 2016-03-31 | $1.51B | $2.19B | 106.14% |
| 2015-12-31 | $0.39B | $1.30B | 28.99% |
| 2015-09-30 | $-0.14B | $0.62B | -9.39% |
| 2015-06-30 | $-0.43B | $1.58B | -24.00% |
| 2015-03-31 | $-0.66B | $1.92B | -34.61% |
| 2014-12-31 | $0.03B | $1.77B | 1.68% |
| 2014-09-30 | $0.27B | $1.96B | 13.15% |
| 2014-06-30 | $0.26B | $1.99B | 11.91% |
| 2014-03-31 | $0.44B | $2.15B | 19.27% |
| 2013-12-31 | $0.31B | $2.25B | 13.12% |
| 2013-09-30 | $0.43B | $2.32B | 18.43% |
| 2013-06-30 | $0.55B | $2.42B | 22.85% |
| 2013-03-31 | $0.56B | $2.35B | 22.21% |
| 2012-12-31 | $0.73B | $2.34B | 27.18% |
| 2012-09-30 | $0.72B | $2.46B | 25.56% |
| 2012-06-30 | $0.70B | $2.93B | 24.11% |
| 2012-03-31 | $0.71B | $2.95B | 23.66% |
| 2011-12-31 | $0.71B | $2.91B | 23.36% |
| 2011-09-30 | $0.71B | $2.87B | 23.21% |
| 2011-06-30 | $0.70B | $3.20B | 22.85% |
| 2011-03-31 | $0.68B | $3.13B | 22.67% |
| 2010-12-31 | $0.65B | $2.96B | 22.13% |
| 2010-09-30 | $0.64B | $2.95B | 22.20% |
| 2010-06-30 | $0.63B | $2.93B | 22.28% |
| 2010-03-31 | $0.58B | $2.83B | 20.99% |
| 2009-12-31 | $0.54B | $2.74B | 19.75% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.003B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.286B | 26.31 |
| Elevance Health (ELV) | United States | $88.874B | 11.47 |
| CVS Health (CVS) | United States | $80.430B | 10.00 |
| DiDi Global (DIDIY) | China | $23.532B | 35.71 |
| Natera (NTRA) | United States | $22.361B | 0.00 |
| BioMerieux (BMXMF) | France | $16.097B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.999B | 0.00 |
| Solventum (SOLV) | United States | $12.948B | 13.71 |
| CochLear (CHEOY) | Australia | $11.388B | 0.00 |
| ICON (ICLR) | Ireland | $11.234B | 10.44 |
| Doximity (DOCS) | United States | $11.054B | 51.17 |
| Revvity (RVTY) | United States | $10.840B | 18.66 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| HealthEquity (HQY) | United States | $9.646B | 42.25 |
| Avantor (AVTR) | United States | $8.906B | 12.94 |
| Medpace Holdings (MEDP) | United States | $8.522B | 22.63 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.107B | 13.93 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.139B | 24.38 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Alignment Healthcare (ALHC) | United States | $3.011B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.972B | 38.65 |
| Concentras Parent (CON) | United States | $2.824B | 16.32 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| Ardent Health Partners (ARDT) | United States | $2.126B | 9.06 |
| GeneDx Holdings (WGS) | United States | $2.056B | 79.20 |
| Premier (PINC) | United States | $1.889B | 14.33 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| PACS (PACS) | United States | $1.591B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.457B | 29.14 |
| Teladoc Health (TDOC) | United States | $1.275B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.210B | 9.21 |
| Establishment Labs Holdings (ESTA) | $1.099B | 0.00 | |
| CareDx (CDNA) | United States | $1.087B | 16.97 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.56 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.678B | 10.26 |
| LifeMD (LFMD) | United States | $0.578B | 0.00 |
| Embecta (EMBC) | United States | $0.572B | 3.85 |
| Enhabit (EHAB) | United States | $0.547B | 45.00 |
| InnovAge Holding (INNV) | United States | $0.543B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.478B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Oncology Institute (TOI) | United States | $0.248B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.089B | 0.00 |
| OncoCyte (OCX) | United States | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.058B | 0.00 |
| ModivCare (MODV) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |